TANGO THERAPEUTICS INC (TNGX)
US87583X1090 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to TNGX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.45. This target is 303.13% above the current price.
TNGX was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about TNGX.
In the previous month the buy percentage consensus was at a similar level.
TNGX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Guggenheim | Maintains | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-07-17 | Jefferies | Initiate | Buy |
| 2024-07-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-07-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-24 | Guggenheim | Maintains | Buy -> Buy |
| 2024-05-24 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-23 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-04 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-03-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-12 | Piper Sandler | Initiate | Overweight |
| 2023-12-08 | B. Riley Securities | Initiate | Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-10 | Wedbush | Reiterate | Outperform |
| 2023-03-28 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-20 | HC Wainwright & Co. | Initiate | Buy |
| 2021-09-20 | SVB Leerink | Initiate | Outperform |
| 2021-09-07 | Guggenheim | Initiate | Buy |
| 2021-09-07 | Wedbush | Initiate | Outperform |
| 2021-09-07 | Goldman Sachs | Initiate | Buy |